Scarica l'app Stockscreener
54.35
1.78%
0.95
Dopo l'orario di chiusura:
54.35
Vaxcyte Inc Borsa (PCVX) Ultime notizie
Vaxcyte, Inc. (PCVX) Stock Analysis: Strong Analyst Consensus and Nearly 94% Upside Potential - directorstalkinterviews.com
Evercore ISI Rates Vaxcyte Inc. (PCVX) as an Overweight Following CDC Changes to Childhood Vaccination Recommendations - Finviz
Analysts Are Bullish on These Healthcare Stocks: Vaxcyte (PCVX), Guardant Health (GH) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Vaxcyte (PCVX), Agilon Health (AGL) and Align Tech (ALGN) - The Globe and Mail
Vaxcyte updates on programs for VAX-31 - The Pharma Letter
Trading the Move, Not the Narrative: (PCVX) Edition - Stock Traders Daily
Vaxcyte (PCVX) Is Up 13.2% After Expanding Late-Stage VAX-31 Program And Manufacturing Plans - Yahoo Finance
Cantor Fitzgerald reiterates Overweight rating on Vaxcyte stock By Investing.com - Investing.com Canada
Guggenheim Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $116 - 富途牛牛
Stocks to watch: Vaxcyte sees RS rating jump to 83 - MSN
Vaxcyte Pushes Next-Gen Pneumococcal Vaccine Into Phase 3 Phase - Benzinga
Vaxcyte (PCVX) Advances VAX-31 Vaccine Trials - GuruFocus
Vaxcyte advances adult and infant programs for Vax-31, a potential best-in-class, next-generation pneumococcal conjugate vaccine - marketscreener.com
Vaxcyte Advances Adult and Infant Programs for VAX-31, a - GlobeNewswire
Vaxcyte stock up on results from mid-stage trial of its pneumococcal vaccine - MSN
Campbell & CO Investment Adviser LLC Cuts Stake in Vaxcyte, Inc. $PCVX - MarketBeat
Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Vaxcyte (NASDAQ:PCVX) Trading 7.4% HigherWhat's Next? - MarketBeat
Aug Update: Can Vaxcyte Inc stock hit record highs againCPI Data & Technical Entry and Exit Alerts - Bộ Nội Vụ
(PCVX) Volatility Zones as Tactical Triggers - Stock Traders Daily
Aug Patterns: Why Vaxcyte Inc. (5VA) stock remains stableTrade Analysis Summary & Proven Capital Preservation Methods - Bộ Nội Vụ
Vaxcyte, Inc. (PCVX) Stock Analysis: A Look At Its 121.74% Potential Upside - DirectorsTalk Interviews
Analyst Calls: Will Vaxcyte Inc. (5VA) stock test record highs in 2025Weekly Stock Analysis & Real-Time Market Sentiment Reports - Bộ Nội Vụ
CEO Change: Why Vaxcyte Inc stock could benefit from AI revolutionQuarterly Trade Summary & Expert Approved Momentum Ideas - moha.gov.vn
How Vaxcyte Inc. stock performs after earningsRecovery Day Options & choose cushioning that matches your runs - Улправда
Why Vaxcyte Inc. (5VA) stock could rally stronglyLong Run Comfort Guide & updated model highlights and notes - Улправда
Cantor Fitzgerald Maintains Overweight on Vaxcyte Amid Vaccine Development and ACIP Meeting - MSN
How Vaxcyte Inc. (5VA) stock responds to bond market2025 Key Lessons & High Conviction Trade Alerts - Улправда
Why Vaxcyte Inc. stock could benefit from AI revolutionJuly 2025 Analyst Calls & Weekly Top Gainers Trade List - Улправда
Why Vaxcyte Inc. stock attracts high net worth investorsJuly 2025 Weekly Recap & Expert Verified Stock Movement Alerts - Улправда
Is Vaxcyte Inc. (5VA) stock positioned for digital growth eraJuly 2025 Macro Moves & Free Community Consensus Stock Picks - Улправда
Will Vaxcyte Inc. (5VA) stock test record highs in 20252025 Trade Ideas & Long-Term Growth Plans - Улправда
Why Vaxcyte Inc. (5VA) stock remains stableMoving Average Strategies & Secret Picks Wall Street Isn’t Talking About - ulpravda.ru
Vaxcyte (PCVX) Gains Positive Outlook with Price Target Boost - GuruFocus
Evercore ISI reiterates Outperform rating on Vaxcyte stock amid CDC changes - Investing.com Canada
Stock Report: Is Vaxcyte Inc stock trading near support levelsSell Signal & Daily Profit Maximizing Trade Tips - moha.gov.vn
Vaxcyte (PCVX) Gains Favor After Immunization Schedule Update - GuruFocus
Vaxcyte, Inc. (PCVX) Stock Analysis: Biotech Innovator With Nearly 100% Upside Potential - DirectorsTalk Interviews
Vaxcyte's Chief Technical Ops Officer Sells Shares - AOL.com
Insider Sell Alert: Harpreet Dhaliwal Sells 9,743 Shares of Vaxc - GuruFocus
Harpreet Dhaliwal Sells 9,743 Shares of Vaxcyte (NASDAQ:PCVX) Stock - MarketBeat
Vaxcyte Inc. (PCVX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Price-Driven Insight from (PCVX) for Rule-Based Strategy - Stock Traders Daily
Vaxcyte, Inc. (NASDAQ:PCVX) Nasdaq Composite Tracks Clinical Progress - Kalkine Media
Vaxcyte shows rising price performance with jump to 81 RS rating - MSN
Trade Alert: Senior Vice President of Finance Of Vaxcyte Elvia Cowan Has Sold Stock - simplywall.st
Vaxcyte (NASDAQ:PCVX) Stock Price Up 3.9%Here's Why - MarketBeat
Vaxcyte Earnings Notes - Trefis
Insider Selling: Vaxcyte (NASDAQ:PCVX) SVP Sells 11,623 Shares of Stock - MarketBeat
Vaxcyte president and CFO sells shares worth $692,100 - MSN
Vaxcyte, Inc. $PCVX Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
2.09%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):